medlinkPulmonary hypertension/medlink is a critical condition that often results in heart failure and death for many patients. In search of...

FR900359, a plant-derived compound, shows potential in treating pulmonary hypertension by targeting unique pathways, offering hope for improved...

 Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2...

Essential Tremor (ET), one of the most common movement disorders, is estimated to affect nearly 7 million individuals in the USA. Generally, ET...

Hypertension affects one in three adults globally, with only one in five controlled. WHO Medical Officer Taskeen Khan estimates saving 76 million...

DALLAS, July 02, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...

Nablus - Ma'an - Patient Kayed Mohammed Mohammed Sawalma appealed to the President to help him and transfer him abroad for treatment and a lung...

MONDAY, July 8, 2024 -- For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or...

Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for...

Athira (ATHA) completes dosing the last patient in the phase II/III LIFT-AD study on fosgonimeton for treating people with mild-to-moderate...